Digital Health Global
FEBRUARY 5, 2024
To bolster this expansion, Vektor will increase clinical support and drive additional clinical studies to showcase the technology’s impact and inform future innovation as well as continue efforts to secure reimbursement. “At TVM also invests in differentiated commercial-stage medical technologies and late clinical-stage therapeutics.
Health Populi
APRIL 1, 2022
To innovate more, and more quickly, across the entire ecosystem of health — in government policies, pharmaceutical innovations, and technology developments. The bar chart illustrates the result of the meta-analysis which considered 148 studies on mortality and risk factors.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Digital Health Global
NOVEMBER 28, 2023
Results from various clinical studies showed significant user benefits – including a 57% reduction in reporting times for clinical actionable PTXs; 1 a 17.7% About GE HealthCare Technologies Inc. 5 “A Pilot Study.” As part of the latest Critical Care Suite 2.1 increase in clinician detection of small PTXs. We are an $18.3
Health Populi
APRIL 6, 2022
This capability is attracting pharmaceutical and life science companies, health care providers and research organizations to take a closer look at Seqster’s offering.
Digital Health Global
FEBRUARY 9, 2024
As we delve into the future of medical technology, several key developments emerge as pivotal in shaping the next wave of healthcare innovation. Digital Therapeutics (DTx) The use of digital tools to treat medical conditions, either as standalone therapies or in conjunction with traditional pharmaceuticals, is only set to grow.
Health Populi
AUGUST 6, 2021
Compared with the ten other countries studied, the Commonwealth Fund placed the U.S. Spending the most money (as a percent of gross domestic product) does not translate into high health care system outcomes, this study concludes. in second position just behind New Zealand which topped the list for care process. ” .
Health Populi
JULY 2, 2018
Most Americans say that pharmaceutical manufacturers, banks, advertisers, energy firms, and tech companies have too much power and influence in today’s American economy, according to Public Attitudes Toward Technology Companies , a research report from the Pew Research Center. Trust underpins health engagement.
Expert insights. Personalized for you.
88 
Let's personalize your content